Health Advance Inc. (HADV)
OTCMKTS · Delayed Price · Currency is USD
0.0003
0.00 (0.00%)
At close: Oct 29, 2025
Health Advance Market Cap
Health Advance has a market cap or net worth of $292.24 thousand as of October 30, 2025. Its market cap has increased by 8.54% in one year.
Market Cap
292.24K
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since September 13, 2012, Health Advance's market cap has decreased from 343.80K to 292.24K, a decrease of -15.00%. That is a compound annual growth rate of -1.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 29, 2025 | 292.24K | 2.90% |
| Dec 31, 2024 | 284.01K | -76.39% |
| Dec 28, 2023 | 1.20M | 17.64% |
| Dec 30, 2022 | 1.02M | -87.29% |
| Dec 31, 2021 | 8.05M | 215.00% |
| Dec 31, 2020 | 2.55M | 245.83% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 798.20M |
| Elite Pharmaceuticals | 655.03M |
| Glass House Brands | 559.28M |
| Northwest Biotherapeutics | 394.58M |
| Silence Therapeutics | 337.25M |
| CytoDyn | 320.50M |
| Nika Pharmaceuticals | 312.10M |
| American Oncology Network | 302.09M |